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Citrate synthase (CS) is a key mitochondrial enzyme. (e aim of this study was to test the hypothesis that low CS activity impairs
the metabolic health of mice fed a high fat diet (HFD) and promotes palmitate-induced lipotoxicity in muscle cells. C57BL/6J (B6)
mice and congenic B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A), a strain which carries the A/J allele of CS on the B6 strain
background, were fed HFD (45% kcal from fat) for 12weeks. C2C12 mouse muscle cells were used to investigate eﬀects of CS
knockdown on cell viability and signalling after incubation in 0.8mM palmitate. CS activity, but not that of β-hydroxyacyl-
coenzyme-A dehydrogenase was lower in the gastrocnemius muscle and heart of B6.A mice compared to B6 mice (P< 0.001).
During HFD feeding, glucose tolerance of mice decreased progressively and to a greater extent in B6.A females compared to B6
females, with males showing a similar trend. Body weight and fat gain did not diﬀer between B6.A and B6 mice. After an 18 h
incubation in 0.8mM palmitate C2C12 muscle cells with ∼50% shRNA mediated reduction in CS activity showed lower
(P< 0.001) viability and increased (P< 0.001) levels of cleaved caspase-3 compared to the scramble shRNA treated C2C12 cells. A/
J strain variant of CS is associated with low enzyme activity and impaired metabolic health. (is could be due to impaired lipid
metabolism in muscle cells.
1. Introduction
Mitochondria play a key role in functioning of skeletal
muscles and metabolic health [1, 2]. Insulin resistance
often coincides with reduced mitochondrial oxidative
capacity in skeletal muscle [3]. Mitochondrial citrate
synthase (CS) has often been used as a biomarker of
mitochondrial content and function in mammals [4, 5].
However, we have recently reported that CS activity in
skeletal muscles of A/J mice is reduced by half compared
to ﬁve other strains of mice [6, 7]. As neither abundance of
the CS protein nor other mitochondrial markers could
explain this reduction, we attributed this phenomenon to
the missense mutation in exon 3 of Cs, i.e., H55N sub-
stitution (A for C, rs29358506) in the A/J mice. (us, mice
carrying the A/J allele of Cs could be a prudent model for
studying the eﬀects of reduced CS activity on such con-
ditions as obesity and diabetes. (is is important in view
of the evidence suggesting that innate impairment in CS
functioning might be responsible for low rates of fatty acid
oxidation and insulin resistance in skeletal muscles of
diabetic patients [8, 9]. If CS plays a causative role, muscle
cells with low CS activity will show accelerated apoptosis
after prolonged incubation in the media enriched with
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palmitate which induces lipotoxicity in muscle cells [10].
Similarly, mice carrying the A/J allele of Cswill be aﬀected by a
more severe impairment in glucose tolerance than the mice
carrying the wild type or C57BL/6J (B6) strain allele ofCswhen
fed high fat diet (HFD) which is known to induce insulin
resistance [11]. Interestingly, A/J mice are more resistant to fat
and weight gain compared to the obesity prone B6 strain
[12, 13].(is diﬀerence in obesity resistance between the strains
might also be associated with CS activity since the chromosome
substitution strain, which carries chromosome 10 of the A/J
strain on B6 strain background, is also obesity resistant [14].
Furthermore, a congenic strain carrying the A/J allele in the
telomeric region of chromosome 10, where the Cs gene resides,
showed higher resistance to obesity than B6 mice [15, 16]. All
these ﬁndings prompted us to investigate the role of the H55N
polymorphism in physiological adaptations to HFD.
(e aim of the study was to test the hypothesis that the
H55N polymorphism aﬀects CS activity and metabolic
health in mice fed HFD. We compared metabolic and
physiological responses to a HFD in B6 mice and congenic
B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice which
carry the A/J allele of the Cs gene on the B6 background [17].
We have also tested the hypothesis about the link between
low CS activity and impairment in lipid metabolism and
lipotoxicity in muscle cells. In these experiments, we ex-
amined eﬀects of reduced Cs expression on muscle cell
viability; ATP levels and production of reactive oxygen
species (ROS) were measured before and after incubation in
the media supplemented with high concentrations of pal-
mitate which induces apoptosis [10].
2. Results
2.1. Chromosome 10 Genotype Is Associated with CS but Not
HAD Activity. (e proximal region of the chromosome 10
was genotyped in order to reﬁne the recombination site in the
congenic B6.A strain (Figure 1). (is analysis conﬁrmed that
congenic B6.A mice carried A/J allele of Cs. We compared
enzyme activity for CS and HAD in the gastrocnemius
muscle and heart of B6 and B6.A mice at the end of HFD
study (Table 1). Activity of these enzymes, especially that of
HAD, was higher (P< 0.001) in the heart compared to the
gastrocnemius muscle. For both tissues, CS activity was also
higher (P< 0.001) in B6 mice than in B6.A mice, but there
were no strain eﬀects on HAD. ANOVA showed that CS and
HAD activity in the gastrocnemius muscle depended on sex
(P< 0.05) as females tended to have lower activity of these
enzymes, but there were no such sex eﬀects on the heart.
2.2. HFD Feeding Leads to a Greater Gain in FatMass ofMale
Mice than FemaleMice. Data on body mass and food intake
in HFD study are presented in Figure 2. Male mice were
always heavier (P< 0.001) than female mice, but there were
only minor strain eﬀects on body weight. During the ﬁrst
two weeks of HFD feeding, B6 males gained more weight
than B6.A males (0.342± 0.069 vs 0.261± 0.104 g/day,
P< 0.05, respectively), but there were no diﬀerences be-
tween the strains among females (0.164± 109 vs
0.173± 117 g/day, respectively) which gained less (P< 0.001)
weight than males. Afterwards, the rate of weight gain
slowed down (P< 0.001), but males continued to gain more
weight than females (P< 0.01) though there were no dif-
ferences between the strains. Similarly, food intake showed
neither eﬀects of strain nor sex. Food intake increased
(P< 0.001) during the ﬁrst week of HFD feeding and then
returned to the original level. Fat mass of mice increased
continuously (P< 0.001) and was smaller in females com-
pared to males (P< 0.01), but did not diﬀer between the
strains. LBM showed only small changes compared fat mass.
B6.A females experienced a small increase (P< 0.05) in LBM
after the two weeks of HFD feeding and B6 males showed a
decrease (P< 0.01) in LBM during the last six weeks of the
feeding. Males had bigger (P< 0.05) LBM than females, but
there were no eﬀects of the strain on LBM.
2.3. Energy Balance and Resting Metabolic Rate Are Not
Dependent on Sex, Strain, or Diet of Mice. Data on energy
balance in the HFD study are presented in Figure 3. (e
covariance analysis, using body mass as a covariate, did not
show any signiﬁcant eﬀect of strain, sex, or diet on MEI or
DEE. (ese factors did not aﬀect RMR either except at the
12weeks of HFD feeding when B6.A males showed higher
RMR compared to B6 males (P< 0.01).
2.4. Physical Activity and Body Temperature. (e data on
physical activity and body temperature of B6 and B6.A mice
in HFD study are shown in Figure 4. Physical activity was
not aﬀected by strain, but was higher for female mice
compared to males (P< 0.001). Mice of both sexes became
less active (P< 0.05) during HFD feeding. (e activity
during the light phase and dark phase tended to be equally
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Figure 1: Genotyping chromosome 10 in congenic B6.A-
(rs3676616-D10Utsw1)/KjnB6 (B6.A) strain. Black, white, and gray
colours mark alleles of C57BL/6J (B6), A/J genotype, and unknown
genotype, respectively. (e chromosomal markers are also in-
dicated. (e data are also presented for congenic (10C1) strain in
[16].
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aﬀected. Body temperature was also higher (P< 0.001) in
females than males and also decreased (P< 0.05) during
HFD feeding. B6.A males had higher (P< 0.01) body tem-
perature during HFD feeding compared to B6 males, but the
strain eﬀect was not signiﬁcant for females.
2.5.TissueFat. Data on tissue fat at the end of HFD study are
presented in Table 2. (ere were no signiﬁcant eﬀects of
strain except that B6.A mice had more (P< 0.05) skin fat
than B6 mice. Male mice had larger fat pads (P< 0.05) and
greater fat content in the carcass and tail (P< 0.05)
Table 1: Mitochondrial enzymes in tissues of C57BL/6J (B6) and B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice.
Males Females
B6 B6.A B6 B6.A
CS H 1834.6± 402.3 1063.6± 281.5∗∗ 1736.4± 338.7 963.4± 205.9∗∗M# 750.9± 129.9 515.7± 96.0∗∗ 644.7± 115.7 417.1± 113.0∗∗
HAD H 151.7± 43.6 131.1± 28.6 137.7± 36.4 140.3± 21.7M# 12.7± 4.0 10.1± 2.6 8.4± 1.7 9.0± 3.7
Citrate synthase (CS) and β hydroxyacyl CoA dehydrogenase (HAD) activity (μmol/min/g protein) in the gastrocnemius muscle (M) and heart (H) of mice
was assessed using spectrophotometric assays for tissue homogenates after 12weeks of high fat diet feeding. (e values are means± SD (n � 8 each). B6 vs
B6.A strains; ∗∗P< 0.001; #males vs. females P< 0.05.
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Figure 2: Body mass and composition of mice. Body mass (a), food intake (b), body fat, (c) and lean body mass (d) in C57BL/6J (B6) and
congenic B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice (M, males; F, females) during the baseline period of high carbohydrate diet
(HCD) followed by high fat diet (HFD) feeding. Values (n � 16 each) are means in A and B as well as means± SEM in (c) and (d) ∗∗P< 0.01,
B6 vs B6.A strains.
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Figure 3: Energy balance and resting metabolic rate of mice. Metabolisable energy intake (MEI) (n � 8 each) (a), daily energy expenditure
(DEE) (n � 8 each) (b), and resting metabolic rate (RMR) (n � 16 each) (c) in C57BL/6J (B6) and congenic B6.A-(rs3676616-D10Utsw1)/
KjnB6 (B6.A) mice (M, males; F, females) fed high carbohydrate diet (HCD) and high fat diet (HFD). Values are means± S.D. ∗∗P< 0.05, B6
vs B6.A strains.
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Figure 4: Physical activity and body temperature. Average daily physical activity (a) and body temperature (b) in C57BL/6J (B6) and
congenic B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice (M, males; F, females). (e mean values for physical activity during the light
phase are marked by white colour.(e data are presented for the baseline period of high carbohydrate diet (HCD) feeding followed by HFD
feeding for 2weeks (HFD2), 6 weeks (HFD6), and 12weeks (HFD12). Values are means± SD (n � 16 each).
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compared to females. Oil red staining revealed higher
(P< 0.05) intramuscular fat content in the tibialis anterior
muscle of male mice compared to female mice, but there
were no eﬀects of strain on this measure.
2.6. Plasma Lipids and Insulin. Data on the fasting levels of
plasma lipids and insulin at the end of HFD study are
presented in Table 3. (e signiﬁcant diﬀerences between the
strains were observed only in males. Plasma FFA and LDL
cholesterol were higher (P< 0.05) in B6.A males compared
to B6 males. A similar trend was observed for TAG
(P � 0.054). Females tended to have lower levels of plasma
lipids than males and the sex eﬀects were signiﬁcant
(P< 0.05) for TAG, total cholesterol, and HDL cholesterol.
Insulin levels were lower in females than males (P< 0.001),
but there were no diﬀerences between the strains.
2.7. Glucose Tolerance. Data on glucose tolerance in HFD
study are shown in Figure 5. Fasting blood glucose levels
increased (P< 0.01) during HFD feeding and were consis-
tently higher (P< 0.001) in males than females in-
dependently of the strain. Blood glucose peaked from 15min
to 60min after intraperitoneal injection of glucose and
decreased afterwards. (e blood glucose AUC was consis-
tently greater in males compared to females (P< 0.001) and
increased (P< 0.001) for both sexes during HFD feeding. B6
females had a lower (P< 0.05) blood glucose AUC than B6.A
females after 6 and 12weeks of HFD (Figures 5(f ) and 5(h)).
A similar trend was observed for males (P � 0.07) at these
time points. Blood glucose values 60min after glucose in-
jection did show a clear strain eﬀect (P< 0.05) for both sexes
as they were higher in B6.A mice compared to B6 mice.
2.8. Low CS Activity Is Associated with High Cellular Toxicity
after Exposure toHigh Extracellular Palmitate Concentration.
Cell growth and stress markers were studied in C2C12
mouse muscle cells treated with Con shRNA and Cs
shRNAwhich targeted CsmRNA. Compared to Con shRNA
cells, Cs shRNA cells showed lower Cs mRNA to β-actin
mRNA ratio (0.022± 007 versus 0.081± 016, respectively,
P< 0.001) and reduced CS activity (406.6± 115.5 versus
199.7± 72.4 μmol/min/g protein, respectively, P< 0.001).
Figure 6 shows data on growth and metabolic stress of these
cells cultured with and without palmitate.
Under the standard conditions of high glucose total cell
staining (indicating number of cells) tended to increase from
12 h to 18 h incubation though this increase was signiﬁcant
(P< 0.05) only for Con shRNA cells. Palmitate supple-
mentation of the cell media caused a marked (P< 0.001)
decrease in total cell staining, and this decrease was greater
(P< 0.001) in Cs shRNA than Con shRNA cells after 18 h
incubation. Caspase-3 to β-actin ratio increased (P< 0.001)
only in Cs shRNA cells and only after palmitate supple-
mentation. (ere were no signiﬁcant diﬀerences between
Con shRNA and Cs shRNA cells in levels of PKB, P-PKB,
AMPK, or P-AMPK proteins. (ere were no signiﬁcant
changes in P-PKB to PKB ratio or the P-AMPK to AMPK
ratio either Figure 7.
3. Discussion
(e aim of the study was twofold. Firstly, we investigated if
the A/J strain variant of H55N polymorphism impairs CS
activity and metabolic health in mice fed HFD. Secondly, we
tested if Cs knockdown promotes palmitate-induced apo-
ptosis in muscle cells. In agreement with our ﬁrst hypothesis,
B6.A mice had low CS activity, tended to accumulate more
subcutaneous fat, and were less tolerant to glucose compared
to B6 mice when fed HFD. Some of the eﬀects of the strain
were sex-speciﬁc as B6.A males but not that females had
higher levels of plasma TAG and LDL cholesterol compared
to B6 mice. In agreement with our second hypothesis ∼50%
knockdown of CS activity accelerated palmitate-induced
apoptosis in C2C12 mouse muscle cells. In summary, the
results of our study suggest that CS activity is of particular
importance for metabolic health but aﬀects neither energy
balance nor preponderance to obesity in mice.
We studied B6mice and congenic B6.Amice which carry
the A/J allele in the telomeric locus of chromosome 10 on B6
strain background [17]. (is locus includes the Cs gene, and
we proposed that histidine replaced by asparagine at the
residue 55 was the main cause of low CS activity in A/J strain
[6]. Our current results support this hypothesis as B6.A mice
had signiﬁcantly lower CS activity than B6 mice in both the
gastrocnemius muscle and heart. Earlier studies that ex-
amined the eﬀects of the telomeric locus of chromosome 10
Table 2: Fat content in tissues of C57BL/6J (B6) and B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice after 12weeks of high fat diet (HFD)
feeding.
Males Females
B6 B6.A B6 B6.A
Fat pads (g)†† 5.818± 1.839 5.526± 1.231 4.397± 1.436 3.932± 1.290
Skin and subcutaneous fat (g)∗ 2.614± 1.178 3.342± 1.448 2.073± 0.670 2.933± 0.726
Carcass and tail fat (g)†† 2.559± 0.668 2.470± 0.563 1.893± 0.651 1.832± 0.493
Organ fat (g) 0.311± 0.084 0.397± 0.341 0.267± 0.157 0.222± 0.062
Liver fat (g) 0.182± 0.174 0.115± 0.081 0.081± 0.030 0.082± 0.030
TA muscle fat (au)†† 15.64± 7.25 15.90± 5.59 11.39± 6.10 11.13± 3.64
Fat content of tissues was assessed using Soxhlet method for fat extractions. Intramuscular fat of the tibialis anterior (TA) muscle was evaluated using staining
of the muscle cross sections with Oil Red dye with the subsequent quantiﬁcation of the staining intensity. (e values are means± SD (n � 8 each). B6 vs B6.A
strains; ††P< 0.01, eﬀect of sex; ∗P< 0.05, eﬀect of strain.
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with a diﬀerent set of congenic strains derived from the same
pair of the founders showed that the presence of A/J allele at
the locus confers obesity resistance [15, 16]. We did not
reproduce this ﬁnding. We started HFD feeding when mice
were 12-week old rather than 5-week old, used the diet with
45% not 60% energy from fat, and continued the feeding for
88 days instead of 100 days. However, it is unlikely that these
methodological diﬀerences could explain the diﬀerences in
the ﬁndings between the studies. (e B6 strain showed
similar weight gains in our study as in the two previous
studies, but the congenic B6.A strain gained much more
weight than the congenic mice in the studies of Burrage et al.
[15] and Shao et al. [16]. It appears that the recombination
between the B6 and A/J alleles in the B6.A strain occurred
slightly closer to the telomere resulting in a shorter insert of
the A/J allele, missing the gene that conferred obesity re-
sistance of the congenic strain used by Shao et al. [16].
(ere were only minor diﬀerences in weight gain
between two strains as B6 males tended to gain weight
faster than B6.A males during the ﬁrst two weeks of HFD.
Nevertheless, B6.A females experienced more rapid
worsening in glucose tolerance than B6 mice when fed
HFD. A similar trend was observed in males. Fasting
insulin levels did not diﬀer between the strains suggesting
that insulin resistance was not implicated in the diﬀer-
ences in glucose tolerance between the strains or diﬀer-
ences in insulin resistance were minor and/or less
pronounced under the fasting conditions. Impaired fatty
acid oxidation is often considered as the major cause of
insulin resistance [1, 18]. Muscle cell cultures of diabetic
patients showed low CS activity and reduced rate of
complete palmitate oxidation compared to the cell cul-
tures derived from the healthy volunteers [8, 9]. It has
been hypothesized that an inborn defect in the CS enzyme
can limit complete fatty acid oxidation in muscle cells and
thus cause insulin resistance in type 2 diabetes [9].
However, diabetic patients present a heterogeneous
population and multiple factors could contribute to low
CS activity and impaired lipid metabolism. Interestingly,
we have also observed elevated blood lipids in B6.A males
and high skin fat content for both sexes of B6.A mice
compared to B6 mice. (ese results support the conten-
tion about importance of CS activity for optimal lipid
metabolism. We tested this hypothesis further using
C2C12 muscle cells which show apoptosis when cultured
in the media supplemented with high palmitate concen-
tration [10]. (is palmitate-induced apoptosis is sensitive
to the rate of fatty oxidation as overexpression of CPT1
which promotes fatty acid oxidation and also reduces
apoptosis in these muscle cells [10]. In agreement with our
hypothesis the cells with CS knockdown showed greater
apoptosis as reﬂected in lower viability and higher levels of
cleaved caspase-3 after 18 h exposure palmitate compared
to the control cells. It has been reported that treatment
with shRNA targeting Cs also increased caspase-3 levels in
mouse’s inner ear cell line [19]. Interestingly, C2C12
muscle cells with reduced CS activity did not diﬀer in
viability from the control cells when cultured in high
glucose media without palmitate supplementation. It
appears that 50% CS knockdown induces only subtle
changes in muscle cell function. PKB and AMPK phos-
phorylation were not aﬀected suggesting that neither
insulin signalling nor ATP levels were reduced. (is can
probably explain why B6 and B6.A mice do not diﬀer in
glucose tolerance at the baseline when they were fed high
carbohydrate diet. Our previous study showed that C2C12
muscle cells with low CS activity accumulated more
ceramide, but only when incubated in the media sup-
plemented with high concentrations of palmitate [20].
Interestingly, hair cells, spiral ganglion neurons, and stria
vascularis in cochleae of A/J mice show degeneration
which is linked to Cs even when these mice are fed a high
carbohydrate diet [17, 19]. It appears that cellular re-
sponse to CS knockdown depends on the cell type [21].
Interestingly, CS activity decreases faster than the activity
of other mitochondrial enzymes in lymphocytes of ageing
humans, and these changes are even more apparent in
obese individuals [22]. (e consequences of these alter-
ations in CS activity are unclear and need to be in-
vestigated further in view of the current ﬁndings
suggesting that physiological mechanisms underlying
glucose tolerance and obesity can be dissociated.
Neither MEI nor DEE diﬀered between B6 and B6.A
mice. (ermoregulation contributed signiﬁcantly to DEE in
our study as mice were housed in separate cages at an
ambient temperature of ∼21°C rather than 30°C which is
Table 3: Fasting levels of plasma lipids and insulin in C57BL/6J (B6) and B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A) mice after 12 weeks of
high fat diet (HFD) feeding.
Males Females
B6 B6.A B6 B6.A
Free fatty acids (mM) (n � 8) 1.30± 0.38 1.69± 0.33∗ 1.47± 0.27 1.48± 0.28
Triacylglycerol (mM)† (n � 16) 1.08± 0.29 1.37± 0.49 0.98± 0.29 1.04± 0.37
Total cholesterol (mM)† (n � 8) 3.96± 1.43 4.86± 0.77 3.93± 0.62 3.67± 0.82†
HDL cholesterol (mM)∗† (n � 8) 0.94± 0.14 0.79± 0.09 0.78± 0.08 0.72± 0.12
LDL cholesterol (mM) (n � 8) 2.15± 1.18 3.54± 0.82∗ 2.72± 0.57 2.29± 0.91†
Insulin (μg L-1)††† (n � 7) 9.39± 3.27 7.19± 3.82 2.78± 0.54†† 2.79± 0.30†
Plasma concentrations of free fatty acids (FFA), triacylglycerol (TAG), total cholesterol (TC, mM), and HDL cholesterol (HDL-C) were assessed using
commercially available kits. LDL cholesterol (LDL-C) concentration was quantiﬁed as suggested by Friedewald et al. [35]. Plasma concentrations of insulin
were measured using a standard enzyme-linked immunosorbent assay (insulin ELISA, # nr 10-1247-01, Mercodia, Sweden). (e values are means± SD.∗P< 0.05, B6 vs B6.A strain; †P< 0.05, ††P< 0.01, †††P< 0.001 males vs females.
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Figure 5: Glucose tolerance. Blood glucose concentrations (mM) and area under curve (AUC) during glucose tolerance tests consisting of
the peritoneal bolus injection of glucose (2 g glucose/kg body weight) in C57BL/6J (B6) and B6.A-(rs3676616-D10Utsw1)/KjnB6 (B6.A)
mice fed high carbohydrate diet (a, b) as well as after for 2weeks (c, d), 6 weeks (e, f ), and 12weeks (g, h) of high fat diet feeding. Values are
means (a c, e, and g) and means± SD (b, d, f, and h). †P< 0.001 males vs females; ∗∗P< 0.001, B6 vs B6.A strains.
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Figure 6: Palmitate-induced lipotoxicity in C2C12 muscle cells. C2C12 muscle cells were treated either with control shRNA (Con shRNA)
or Cs shRNA which targeted Cs mRNA. Afterwards Con shRNA and Cs shRNA cells were incubated in the media containing 5.5mM
glucose (G) and/or 0.8mM palmitate (P). (a) Cell proliferation was assessed using cell counting assay kit-8 (96992, Sigma, UK) and veriﬁed
by (b) crystal violet staining; (c) cellular ATP concentrations were assessed using ATP calorimetric assay (ab83355, Abcam, Cambridge,
UK); (d) levels of cleaved caspase-3 were assessed using immunoblotting; (e) production of reactive oxygen species was assessed by
measuring 2′, 7′-dichlorodihydroﬂuorescein diacetate (H2DCFDA) ﬂuorescence (values are means± SEM). ∗∗P< 0.01, B6 vs B6.A strains.
†p< 0.001 G vs G+P; ∗∗∗P< 0.001, Con shRNA vs Cs shRNA.
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within the thermoneutral zone for mice [23, 24]. (e A/J
mice have somewhat impaired thermoregulation as they are
not able to maintain body temperature at the ambient
temperature of 15°C [13]. However, all mice maintained
their body temperature and B6.A males tended to show even
higher body temperature than B6 mice in our study. B6.A
males also showed a slightly higher RMR compared to B6
males after 12weeks of HFD feeding. (is could be due to
marginally greater fat free mass of B6.A males. Physical
activity did not depend on the strain. It appears that low CS
activity leads to neither deﬁcient thermoregulation nor al-
terations in energy balance when mice are maintained at
temperatures slightly below the thermoneutral zone.
We studied mice of both sexes. Females tended to gain
weight at a slower rate and showed better glucose tolerance
than males throughout the whole duration of HFD study.
(is could be at least partially due to higher levels of physical
activity in females compared to males. Indeed, increased
levels of physical activity can reverse impairments in muscle
metabolism even in rats selected for low running capacity
[25]. However, in contrast to males, female mice also show
an increase in population of anti-inﬂammatory T cells in
adipose tissue and no clear signs of low grade inﬂammation
which is a key contributor to insulin resistance during HFD
feeding [26, 27]. (ere is also evidence that brown adipose
tissue (BAT) of female rats shows higher expression of
numerous proteins involved in thermogenesis and fat oxi-
dation as well as lower expression of proteins contributing to
fat synthesis compared to male rats [28]. (us, several
factors might have contributed to better glucose tolerance in
female mice compared to male mice. Interestingly, CS and
HAD activity of bothmitochondrial enzymes (CS and HAD)
tended to be somewhat lower in the gastrocnemius muscle of
females compared to males. It appears that small reduction
in the mitochondrial enzyme activity does not have a sig-
niﬁcant impact on insulin resistance during HFD feeding
which promotes insulin resistance in mice [29, 30].
In summary, low CS activity is associated with impaired
glucose tolerance and abnormalities in lipid metabolism
which are more prevalent in males compared to females, but
aﬀects neither weight nor fat gain in mice fed HFD.
4. Materials and Methods
4.1. Animals and Measurements. Firstly, we tested the hy-
pothesis that low CS activity impairs metabolic health of
B6.A and B6 mice fed HFD. All procedures concerning
animal care and treatment were approved by the Ethical
committee for the use of experimental animals of the
University of Aberdeen and licensed by the UKHome Oﬃce
(PPL 60/4366). For this study, males and females of C57BL/
6J (B6) and congenic B6.A-(rs3676616-D10Utsw1)/KjnB6
(B6.A) strains were purchased from Harlan (Charles River
Laboratories, Wilmington, Massachusetts, USA) and the
Jackson Laboratories (Bar Harbour, ME, USA), respectively.
Mice were maintained in a temperature controlled room
(21± 1°C) under a 12-h to 12-h light to dark cycle. Mice were
individually housed in standard cages with ad libitum water
and standard chow (CRM pellets, SDS diets, U.K.). Sixteen
male and 16 female mice of both B6 and B6.A strains were
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Figure 7: Palmitate-induced lipotoxicity in C2C12 muscle cells (Cont). C2C12 muscle cells were treated either with control shRNA (Con
shRNA) or Cs shRNA which targeted Cs mRNA. Afterwards Con shRNA and Cs shRNA cells were incubated in the media containing
5.5mM glucose (G) and/or 0.8mM palmitate (P). (a) Eﬀect of palmitate exposure on the phosphorylation of AMPK ( r 172) in Con
shRNA and Cs shRNA cells using western blot analysis. Quantiﬁcation of immunoblots from six experiments. P.AMPK was normalized to
AMPK. (b) Eﬀect of palmitate exposure on the phosphorylation of PKB (Ser473) in Con shRNA and Cs shRNA cells. Quantiﬁcation of
immunoblots from six experiments. P.PKB was normalized to PKB. Control cells with 5.5mM glucose were used as reference. Protein load:
25 µg expression. Values are means± SEM.
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studied (total n � 64). All mice were implanted in-
traperitoneally with body temperature transmitters (PDT-
4000 E-Mitter; Mini Mitter Bend, OR, USA) under general
anaesthesia (mixture of isoﬂurane and oxygen) at approx-
imately 8 weeks of age. Mice were allowed at least 7 days to
recover from the surgery before they were put on a low fat
high carbohydrate diet (HCD, D12450B, 10% kcal fat, 70%
kcal carbohydrate, Research Diets, New Brunswick, NJ,
USA). Baseline measurements then started at the age of
10weeks and were taken over a period of 2weeks. At
12weeks of age all mice were switched to the HFD (D12451,
45% kcal from fat, Research Diets, New Brunswick, NJ,
USA). Body weight (BW) and food intake (FI) were mon-
itored, just prior to lights oﬀ, 3 times a week (Mondays,
Wednesdays, and Fridays) throughout the experimental
protocol. During the baseline period and after 2, 6, and
12weeks of HFD, fat mass, resting metabolic rate (RMR),
and glucose tolerance (GT) were measured as described
below. We also assessed daily energy expenditure (DEE)
using the doubly labelled water technique at the baseline and
after 12weeks of HFD feeding.
Body temperature (Tb) and physical activity (PA) were
recorded for a period of 7 days every 4–6weeks throughout
the experimental protocol by placing mice in their home
cage onto transponder energizers (ER-4000 Receiver, Mini
Mitter Company Inc., USA). (e VitalViewTM Data Ac-
quisition System (MiniMitter Company, Inc, USA) was used
to collect the data in 1min intervals, and PA counts and Tb
(°C) were calculated as daily means over the 7-day period.
After 13weeks of HFD, mice were fasted for 4 h and
euthanized by CO2 and blood samples were taken by cardiac
puncture. For 8 out 16 randomly selected mice from each
experimental group, heart and gastrocnemius muscle and
tibialis anterior from the left hindlimb were excised and snap
frozen in isopentane precooled by liquid nitrogen and stored
at −80°C for analysis of mitochondrial enzymes or in-
tramuscular fat. For the remaining 8 mice, fat pads, carcass,
tail, skin (including subcutaneous fat), liver as well as
thyroid, heart, lungs, gonads, kidneys, spleen, stomach, large
intestine, small intestine, and brain were taken to perform
chemical analysis of fat content.
4.2. Food Intake. Gross energy intake with food was assessed
using similar methods as previously described [31]. Food
intake was calculated from the diﬀerence between the food
given and the food residue. Food samples were taken to
determine the water content. (e energy density of dry food
and faeces was determined by Parr1281 oxygen bomb cal-
orimetry (Parr Instrument, Moline, IL, USA). Metabolisable
energy intake (MEI, kJ day−1) was calculated as follows:
gross energy intake � dry food intake × food energy density,
MEI � gross energy intake− dry faecesmass
× faeces energy density − urinary energy loss.
(1)
Energy loss with urine was assumed to be 3% of gross
energy intake.
4.3. Daily Energy Expenditure. We measured daily energy
expenditure (DEE) using the doubly labelled water tech-
nique [32]. Animals were weighed to a precision of 0.01 g
and injected intraperitoneally with approximately 0.20 g of
water containing enriched 18O (27.8·atom%) and 2H
(15.9·atom%). Syringes were weighed before and after ad-
ministration (±0.0001 g) to calculate the mass of doubly
labelled water injected. Blood samples were taken after 1 h of
isotope equilibration to estimate initial isotope enrichments
and were also collected from unlabelled animals to estimate
the background isotope enrichments. Blood samples were
immediately heat sealed into two 50 μl glass capillaries and
stored at room temperature. A ﬁnal blood sample was taken
approximately 48 h later to estimate isotope elimination
rates. Capillaries that contained the blood samples were then
vacuum distilled, and water from the resulting distillate was
used to produce CO2 and H2. (e isotope ratios 18O to 16O
and 2H to 1H were analysed using gas source isotope ratio
mass spectrometry (ISOCHROMμGAS system and Iso-
Prime IRMS, Micromass, Manchester, UK). (ree high-
enrichment standards were analysed each day alongside
the samples. Isotope enrichments were converted to CO2
production as previously explained [32].
4.4. RestingMetabolicRate. Resting metabolic rate (RMR) of
all measurements took place during the light phase between
0700 and 1600 as described previously [23]. Brieﬂy, air was
pumped (Charles Austin Pumps) through a sealed Perspex
chamber within an incubator (INL-401N-010, Gallenkamp)
set at 30°C, i.e., within the thermo-neutral zone for the mice
[24]. Mass-ﬂow controllers (MKS Instruments UK,
Cheshire, UK) produced 500–700ml O2/min. Air that leaves
the animal chamber was dried by silica gel and 150mlmin−1
was passed through a gas analyser (Servomex 1100A or
Servomex Xentra, Servomex Ltd, Crowborough, UK). Gas
concentrations were measured continuously, and mean
values were stored every 30 s for 3 hours. RMR ﬁnal
quantiﬁcation was measured as the oxygen consumption
over the lowest 20 consecutive values (10min interval) and
corrected for ambient temperature and pressure. Data then
were converted to energy equivalents using an oxycaloriﬁc
value of 21.117 Jml−1 O2, derived from the Weir equation
[33].
4.5.BodyComposition. Fat mass (FM) of mice wasmeasured
using dual energy X-ray absorptiometry (DEXA; PIXImus2
Series Densitometers with software version 1.46.007; GE
Medical Systems Ultrasound and BMD, Bedford, UK). Mice
were anesthetized by inhalation of a mixture of isoﬂurane
and oxygen for the duration of the scan (∼3min). (e head
was excluded from the analysis of body fat [34].
4.6. Tissue Fat. Extraction of tissue fat was carried out using
the Soxhlet method. Dry organs, fat pads, and carcasses with
tail were placed into extraction thimbles (FB59483; Fisher
brand, London, UK) weighed and placed into the extraction
tube of the Soxhlet apparatus. Diethyl ether (BH code
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281326G, VWR, Poole, Dorset, UK) was dripped throughout
the extraction thimble until the solvent was clear in the tube.
Tissue fat mass was calculated by subtraction of dry mass of
sample and thimble after and before extraction.
4.7. Intramuscular Fat. (e transverse sections from the
belly of the tibialis anterior muscle were cut at a thickness of
10 μm with a cryotome (Leica CM1850UV) at −20°C. (e
sections were ﬁxed in 4% formaldehyde (Sigma, UK) for 1 h,
washed by deionized water before incubating the slides with
a 6mM Oil Red dye diluted in isopropanol for 30minutes.
Intensity of the sample staining was then assessed using
Image J software (National Institute of Health, USA) by
measuring the diﬀerence in intensities between red and blue
colours.(e staining of the background was subtracted from
the sample staining.
4.8. Mitochondrial Enzymes. (e enzyme activity was ana-
lysed as in our previous studies [6, 20]. Samples of gas-
trocnemius muscle and hearts were homogenized in 10
volumes of ice cold lysis buﬀer (50mM Tris–HCl, 100mM
KHPO4, 2mM ethylenediaminetetraacetic acid, 0.2% wt./vol
bovine serum albumin (BSA), pH was adjusted to 7.0). (e
homogenates were shaken for 60min and centrifuged at 13
000 g for 10min. (e supernatants were taken and the
protein concentration was measured using the Bradford
assay. (en, measurements of citrate synthase (CS) and
β-hydroxyacyl-coenzyme (CoA) dehydrogenase (HAD)
activity were carried out at room temperature of 21°C using
the spectrophotometer (GENESYS 10 Bio UV-Vis, (ermo
Fisher Scientiﬁc Inc., Waltham, MA, USA). For the CS assay,
the molar extinction coeﬃcient used was 13 600M−1 cm−1
for CoA-5,5′-thiobis(2-nitrobenzoic acid) at 412 nm. (e
reaction reagent consisted of 100mM triethanolamine-HCl,
dithiobis(2-nitrobenzoic acid), 0.5mM Triton-X (0.25% vol/
vol), oxaloacetate, and 0.31mM acetyl CoAwith pH adjusted
to 8.0. CS from a porcine heart was used as a standard
(C3260-200UN, Sigma-Aldrich Company Ltd, Gillingham,
Dorset, UK) for assay calibration. For HAD assay, the molar
extinction coeﬃcient used was 63,000M−1 cm−1 for NADH
at 340 nm. (e reaction reagent consisted of 100mM tet-
rasodium pyrophosphate, 0.23mM NADH, and 0.24mM
acetoacetyl CoA with pH adjusted to 7.3. (e 1000 μL of
reaction reagent included 20 μL of muscle homogenate.
4.9. Glucose Tolerance. (e overnight fasted mice were
subject to an intraperitoneal glucose injection (2 g glucose
(kg body wt)−1). Blood glucose was measured with a gluc-
ometer (ACCU-Chek Aviva, Roche, West Sussex, UK) using
the whole blood samples taken from cut tail tips immediately
before and at 15, 30, 60, and 120min after the injection. (e
area under curve for changes in blood glucose over time or
blood glucose AUC was calculated using Prism 5.0 software.
4.10. Plasma Lipids and Insulin. After heart puncture blood
was collected into 2ml containers and centrifuged (5702/R,
Eppendorf, Hauppauge, USA) at 1500 g at 4°C for 10min,
plasma concentrations of free fatty acids (FFA), tri-
acylglycerol (TAG), total cholesterol (TC, mM), and HDL
cholesterol (HDL-C) were assessed using commercially
available kits (Randox, Crumlin, U.K.), using the spectro-
photometer (GENESYS 10 Bio UV-Vis, (ermo Fisher
Scientiﬁc Inc., Waltham, MA, USA). LDL cholesterol (LDL-
C) concentration was determined as previously described
[35]. Plasma insulin concentrations were measured in du-
plicates using the enzyme-linked immunosorbent assay
(insulin ELISA, # nr 10-1247-01, Mercodia, Sweden) and the
spectrophotometric plate reader (Synergy HT Multi-Mode
Microplate Reader, BioTek, UK).
4.11. Genotyping. (e proximal boundary of the congenic
region in the B6.A strain was genotyped in order to reﬁne the
recombination site. Genomic DNA was extracted from muscle
tissue obtained of B6.A as well as B6 and A/J, to provide
positive control, using the hot sodium hydroxide and Tris
(HotSHOT) method [36] Genomic segments ﬂanking four
SNPs partitioning the region of interest and polymorphic
between the B6 and A/J strains were ampliﬁed by PCR using
pairs of primers provided in parenthesis; rs29356783 (forward-
AAGAGGAAGAGCCGAAAAGG; reverse-TAGGCATGATC
AAGCACGAG), rs232632450 (GGGAATCAAACCCAGATC
CT;ATGTGGGTCCCAGAAATCAA), rs48666233 (TAAATT
TCAGGCGAGCTGGT; GCCTTTTCTTTCCTCCGTCT) and
rs45825880 (TCCTTGTCGAGCTCCTCCTA; CCTCTTGGG
AGGAAACAAGG). (e amplicons were afterwards digested
using AluI ( ermo Scientiﬁc, UK), BtgI (New England
Biolabs, UK), HpyCH4V (New England Biolabs, UK) or NciI
(Fermentas Life Sciences, UK) restriction enzymes, respectively,
following manufacturer recommendation. (e digests were
separated on 2% agarose gel, imaged, and inspected for pres-
ence of the B6 or A/J allele.
4.12. Cell Cultures and Experiments. C2C12 mouse muscle
cells were used to investigate the eﬀects of reduced CS activity
on palmitate-induced lipotoxicity. (e cells were cultured in
growth medium containing 88% (vol/vol) Dulbecco’s Mod-
iﬁed Eagle’s medium (DMEM), 5.5mM glucose, 10% (vol/
vol) fetal calf serum (FCS), and 2mM glutamine in T75 cm2
ﬂasks at 37°C and 5% CO2 as previously described [37]. (en,
lentivirus-delivered stable gene silencing was applied to knock
down Cs expression in the cells [38]. Pseudoviruses were
produced by cotransfecting HEK293 cells with a plasmid
carrying shRNA and the Mission lentiviral packaging mix
(SH001, Sigma–Aldrich) containing plasmids expressing viral
packaging genes and a heterologous viral envelope gene. We
used shRNA (GCACCCAACATTTGAGTTATTCTCGA-
GAATAACTCAAATGTTGGGTGC) which targets the
3′untranslated region (UTR) of Cs mRNA (Cs shRNA) and
control shRNA (Con shRNA) containing random sequence.
(e shRNA was delivered within the pLKO.1-puro vector
containing the puromycin resistance marker. Virus was
harvested in the culture supernatant at 72 h posttransfection,
and transductions of C2C12 cells were carried out in the
presence of 10mg l−1 of polybrene. After transduction, cells
were selected in 3mg l−1 of puromycin for 3 days and then
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used in the experiments with palmitate incubation. For these
experiments, 2×106 cells were seeded in six well plates coated
with extracellular matrix gel (E6909, Sigma-Aldrich, MO,
USA) and containing 2ml of the growth medium.When cells
became conﬂuent, the medium was changed to the diﬀer-
entiation medium containing 96% DMEM, 5.5mM glucose,
2% horse serum, and 2mM glutamine. (e extent of shRNA-
mediated Cs knockdown was assessed using the real time RT-
PCR and measurements of CS activity using the spectro-
photometric CS assay on Cs shRNA and Con shRNA cells. In
experiments with glucose (G experiments), the diﬀerentiated
Cs shRNA and Con shRNA myotubes were incubated in the
diﬀerentiation media supplemented with 2% (wt/vol) fatty
acid-free BSA and 1.2mML carnitine for up to 18 h. In
experiments with mixture of glucose and palmitate (G+P
experiments), 0.8mM palmitate was added to the media. (e
experiments were repeated at least three times for cellular
assays which included measurements of cell proliferation,
ATP levels, cleaved caspase-3 levels, and reactive oxygen
species (ROS) production, respectively.
4.13.CellProliferation. Cell proliferation was assessed using
two independent methods. Firstly, cell counting assay kit-8
(96992, Sigma, UK) was used. ∼106 of cells was lysed in 6
well plates, and light absorbance of lysates was measured at
450 nm using the spectrophotometer. Secondly, crystal
violet staining was applied [39]. For these measurements,
the cells were ﬁxed by incubating them in 45% (vol/vol)
formalin solution (#HT501128, Sigma-Aldrich, St-Louis,
MI, USA) at room temperature for 30min. (e cells were
then washed in phosphate buﬀered saline (PBS) and left to
dry. (e crystal violet solution was made by solubilizing 1 g
of the dye powder (#C3886, Sigma-Aldrich, St-Louis, MI,
USA) in 200ml of 10% (vol/vol) acetic acid. 50 μl of the dye
solution was applied to the ﬁxed cells. (e cells were then
washed three times in PBS to remove all the excess dye.
Afterwards 100 μl of the lysis buﬀer (50mM tris hydrox-
ymethyl aminomethane-hydrocloride, 1mM ethylene di-
amine tetracetic acid, 1mM ethylene glycol tetra acetic
acid, 1% (vol/vol) Triton X-100, 0.1% (vol/vol) 2-mer-
captoethanol, 10mM β-glycerophosphate, 50mM NaF,
and 0.5mM Na3VO4, 2% (vol/vol) protease inhibitor
cocktail, pH of 7.5) was applied to lyse the cells. (e light
absorbance was measured in 20 μl of the lysate in triplicates
at 590 nm wavelengths (Synergy HT Multi-Mode Micro-
plate Reader, BioTek, UK).
4.14. Cell Metabolism and Stress
4.14.1. Real-Time RT-PCR. Cs shRNA and Con shRNA cells
were homogenized in 1ml of ice cold TRIZOL Reagent
(Invitrogen Ltd, Paisley, UK) and RNA extracted using
chloroform and isopropanol as described previously [6]. 2 μg
of RNA was then used for cDNA synthesis in 20 μl reaction
volume containing 50mM Tris-HCl (pH 8.3), 75mM KCl,
3mM MgCl2, 0.5mM dNTP Mix (0.5mM each dATP,
dGTP, dCTP and dTTP), 5mM DTT, 150 ng of random
primers, and 200 units of SuperScript™ III Reverse
Transcriptase. Real time PCR was performed using Roche
Lightcycler 480 II (Roche Diagnostics, Sussex, UK) and
Multiplex Taqman assays for Cs as a target gene and β-actin
as a reference gene in each sample. (ree μL of cDNA was
added to 10 μL of LightCycler 480 Probe Master (Roche),
0.2 μL of TaqMan probe (Probe no. 100, Universal Probe
Library), 0.2 μL of forward and reverse primers (20 μM)
each, and 1 μL of mouse β-actin probe dye VIC-MGB
(Applied Biosystems, 4326317E). (e mouse Cs intron
spanning primers were designed using Universal Probe li-
brary software and purchased from Sigma-Genosys (forward
primer: 5′-GGAAGGCTAAGAACCCTTGG-3′ and reverse
primer: 5′-TCATCTCCGTCATGCCATAGT-3′) and the
corresponding UPL probe (UPL probe #100) was used. (e
results were analysed using LightCycler® 480 software 1.5and Cs was normalized to β-actin and presented as a ratio
(ratio � (1 +ECs)−Ct(Cs)/(1 +Eβ-actin)−Ct(β-actin)).
4.14.2. Western Blotting. (e cell media was removed and
100 μl of the ice cold lysis buﬀer was applied. (e lysed cells
were transferred into the plastic tubes and snap frozen in the
liquid nitrogen. Afterwards, the cells were thawed, ho-
mogenized using homogenizer (ULTRA-TURRAX, Rose
Scientiﬁc, Edmonton, Canada), shaken for 60min, and
centrifuged at 13,000 g for 10min at 4°C. (e supernatants
were taken, the protein concentration was measured using
the Bradford assay, and samples with equal protein con-
centration were made in Laemmli buﬀer as in our previous
studies [37]. 25 μg of protein was usually loaded per lane on
10% polyacrylamide gel, separated using SDS-PAGE elec-
trophoresis and transferred to polyvinylidene ﬂuoride
(PVDF) membrane. (e membranes were washed with Tris
buﬀered saline (TBS) containing 0.1% (vol/vol) Tween-20
(TBS-T buﬀer) before two hour incubation in the blocking
buﬀer (5% (wt./vol) nonfat milk in TBS-T buﬀer). (e
membranes were incubated for 18 h at 4°C with a primary
antibody at 1 :1000 dilution (vol/vol) TBS-T buﬀer sup-
plemented with 5% bovine serum albumin. All antibodies
were from Cell Signalling Technology (Danvers, MA, USA).
(e primary antibodies of caspase-3 (#9662), phospho-Akt
(Ser473) (#9271), Akt (#9272), AMPK (#2532), phospho-
AMPKα ( r172) (#2531) and β-actin (#4967s) were pre-
pared at 1 :1000 in blocking buﬀer (20mM Tris buﬀer saline,
5% (wt./vol) bovine serum albumin, 0.1% (vol/vol) Tween).
After incubation with a primary antibody, membranes were
washed in TBS-T buﬀer and exposed for 2 h to HRP-
conjugated secondary antibody (#7071) at 1 : 2000 dilution
in the blocking buﬀer. (e imaging of blots was performed
using ECL reagent (Amersham Biosciences, Buck-
inghamshire, UK) and Fluor-SMax Imager (Bio-rad, Hert-
fordshire, UK). (e images were quantiﬁed using Image J
(NIH, USA) software.
4.15.DataAnalysis. Data analysis was performed using SPSS
and Prism 5.0 software. Values were expressed as
means± SD unless otherwise indicated. General linear
models were used in the analysis. Analysis of covariance
(ANCOVA), with body mass as a covariate, was applied to
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RMR, DEE, and MEI data. Repeated measures analysis of
variance (ANOVA) was used in case of body weight (BW),
body fat (BF), lean body mass (LBM), food intake (FI),
mitochondrial enzyme activity, physical activity (PA), body
temperature, and data on glucose tolerance. ANOVA was
also used to assess eﬀects of CS knockdown as well as type
and duration of treatment on crystal violet staining and
intracellular signalling in C2C12 cells. (e t-test with a
Bonferroni correction for multiple comparisons was used as
a post hoc test. All the tests were two-tailed with the sig-
niﬁcance level set at P< 0.05.
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